HRS-1597
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 10, 2026
Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 Study
(clinicaltrials.gov)
- P1 | N=78 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.
New P1 trial • Metabolic Disorders • Obesity
1 to 1
Of
1
Go to page
1